MARKET WIRE NEWS

Time To Take Profits On Gilead Sciences (Rating Downgrade)

Source: SeekingAlpha

2026-02-20 14:24:17 ET

Shares of Gilead Sciences, Inc. ( GILD ), my favorite in the HIV drugs market, have risen 23.3% since my previous article , " Gilead Sciences: From All-Time Highs To Higher Highs. "...

Read the full article on Seeking Alpha

For further details see:

Time To Take Profits On Gilead Sciences (Rating Downgrade)
GlaxoSmithKline Plc

NASDAQ: GLAXF

GLAXF Trading

0.0% G/L:

$28.26 Last:

159 Volume:

$28.26 Open:

mwn-alerts Ad 300

GLAXF Latest News

GLAXF Stock Data

$123,941,620,346
2,019,018,428
0.4%
538
N/A
Pharmaceuticals
Healthcare
GB
London

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App